Stock 002432 ANDON HEALTH CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Andon Health Co., Ltd.

Equities

002432

CNE100000Q84

Medical Equipment, Supplies & Distribution

End-of-day quote Shenzhen S.E.
Other stock markets
 03:30:00 09/05/2024 am IST 		5-day change 1st Jan Change
45.21 CNY -3.64% Intraday chart for Andon Health Co., Ltd. +12.77% +20.02%
09/05 Andon Health's Subsidiary Gets US FDA's Nod to Market COVID-19, Influenza Test Kit MT
08/05 Andon Health's US Unit Gets FDA Emergency Use Authorization for 3-in-1 Home Test Kits MT

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 2,225 2,199 3,995 23,126 23,314 17,604
Enterprise Value (EV) 1 2,005 1,665 3,164 22,163 11,872 7,798
P/E ratio 171 x 33.9 x 16.5 x 24.8 x 1.49 x 13.6 x
Yield - - 0.65% 1.41% 4.89% 0.8%
Capitalization / Revenue 3.95 x 3.11 x 1.99 x 9.65 x 0.89 x 5.45 x
EV / Revenue 3.56 x 2.36 x 1.58 x 9.25 x 0.45 x 2.41 x
EV / EBITDA -18.4 x -9.6 x 7 x 23.5 x 0.64 x 9.88 x
EV / FCF -3.89 x -106 x 11.4 x -5,198 x 1.03 x 6.96 x
FCF Yield -25.7% -0.95% 8.76% -0.02% 97.3% 14.4%
Price to Book 1.44 x 1.32 x 2.12 x 7.86 x 1.23 x 0.9 x
Nbr of stocks (in thousands) 4,32,806 4,32,806 4,32,806 4,66,729 4,56,157 4,67,322
Reference price 2 5.140 5.080 9.230 49.55 51.11 37.67
Announcement Date 29/04/19 28/06/20 27/04/21 29/04/22 28/04/23 28/04/24
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 563.9 706.3 2,008 2,397 26,315 3,231
EBITDA 1 -109.1 -173.5 452.2 943.2 18,528 789.1
EBIT 1 -132.7 -200.5 423.6 919.3 18,497 752.7
Operating Margin -23.53% -28.39% 21.09% 38.35% 70.29% 23.29%
Earnings before Tax (EBT) 1 -4.93 18.38 239.8 999.6 18,258 1,580
Net income 1 12.69 66.45 242.3 908.6 16,030 1,252
Net margin 2.25% 9.41% 12.07% 37.91% 60.92% 38.74%
EPS 2 0.0300 0.1500 0.5600 1.999 34.30 2.767
Free Cash Flow 1 -516.1 -15.77 277.1 -4.264 11,552 1,121
FCF margin -91.53% -2.23% 13.8% -0.18% 43.9% 34.7%
FCF Conversion (EBITDA) - - 61.29% - 62.35% 142.09%
FCF Conversion (Net income) - - 114.37% - 72.07% 89.58%
Dividend per Share - - 0.0600 0.7000 2.500 0.3000
Announcement Date 29/04/19 28/06/20 27/04/21 29/04/22 28/04/23 28/04/24
1CNY in Million2CNY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2022 Q1 2022 S1 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3
Net sales 1 - - - 1,726 1,495 787.3 462.3
EBITDA - - - - - - -
EBIT - - - - - - -
Operating Margin - - - - - - -
Earnings before Tax (EBT) - - - - - - -
Net income 14,312 15,244 806.7 - - - -
Net margin - - - - - - -
EPS 30.45 32.44 1.718 - - - -
Dividend per Share - - - - - - -
Announcement Date 29/04/22 29/08/22 28/10/22 28/04/23 28/04/23 29/08/23 31/10/23
1CNY in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 219 533 831 964 11,443 9,806
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 -516 -15.8 277 -4.26 11,552 1,121
ROE (net income / shareholders' equity) -0.2% 1.73% 13.8% 40.1% 144% 6.77%
ROA (Net income/ Total Assets) -4.14% -6.51% 12% 18% 90.1% 2.12%
Assets 1 -306.5 -1,020 2,013 5,052 17,791 59,002
Book Value Per Share 2 3.560 3.840 4.350 6.300 41.50 41.70
Cash Flow per Share 2 1.010 0.7700 2.110 1.960 11.60 5.340
Capex 1 180 60.7 53.8 70.4 212 213
Capex / Sales 31.87% 8.6% 2.68% 2.94% 0.81% 6.58%
Announcement Date 29/04/19 28/06/20 27/04/21 29/04/22 28/04/23 28/04/24
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Quarterly earnings - Rate of surprise

Company calendar

Sector Diagnostic & Testing Substances

1st Jan change Capi.
ANDON HEALTH CO., LTD. Stock Andon Health Co., Ltd.
+20.02% 3B
BIOMÉRIEUX Stock bioMérieux
-1.34% 12.58B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD. Stock Shenzhen New Industries Biomedical Engineering Co., Ltd.
-1.64% 8.51B
DIASORIN S.P.A. Stock DiaSorin S.p.A.
+0.09% 5.29B
LANTHEUS HOLDINGS, INC. Stock Lantheus Holdings, Inc.
+22.42% 5.16B
AUTOBIO DIAGNOSTICS CO., LTD. Stock Autobio Diagnostics Co., Ltd.
-0.09% 4.55B
10X GENOMICS, INC. Stock 10x Genomics, Inc.
-52.84% 3.04B
MYRIAD GENETICS, INC. Stock Myriad Genetics, Inc.
+31.92% 2.17B
GUANGZHOU WONDFO BIOTECH CO.,LTD Stock Guangzhou Wondfo Biotech Co.,Ltd
-2.45% 1.92B
SANSURE BIOTECH INC. Stock Sansure Biotech Inc.
+6.45% 1.64B
Diagnostic & Testing Substances
  1. Stock Market
  2. Equities
  3. 002432 Stock
  4. Financials Andon Health Co., Ltd.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW